Heading background

Faruqi Law Blog

Latest on Facebook

Page 2 of 59

Motion to Dismiss Opposed in Exforge Pay-for-Delay Antitrust Suit

October 26th, 2018

Faruqi & Faruqi represents a proposed class of direct purchasers of high blood pressure drug Exforge in a pay-for-delay antitrust suit against Novartis and Par Pharmaceutical.  Faruqi seeks recovery of overcharges paid by wholesalers and others.  The complaint alleges Novartis and Par agreed to allocate the market for Exforge, and restrict output of cheaper generic Exforge.  To induce...

Read full post

The SEC Issues Investigative Report Cautioning Public Companies To Consider Cyber Threats When Implementing Internal Accounting Controls

October 23rd, 2018

The United States Securities and Exchange Commission (“SEC”) issued an investigative report on Tuesday, October 16, 2018 cautioning public companies to consider cyber threats when implementing internal accounting controls.  See Press Release. The SEC’s investigation focused on the internal accounting controls of nine issuers in a variety of industries who each lost at least $1 million...

Read full post

New California Law on Blockchain Technology

October 23rd, 2018

California recently passed Senate Bill No. 838 (the “Bill”), which will allow private and social purpose corporations incorporated in-state to use blockchain technology to issue stock and keep corporate records via blockchain technology.  Blockchain is the technology behind cryptocurrencies like Bitcoin and Ethereum that have garnered recent excitement from investors and consternation...

Read full post

It May Be Fall But the Generic Pricing MDL Springs Forward

October 18th, 2018

On October 16, 2018, the United States District Court for the Eastern District of Pennsylvania (Rufe, J.) entered an opinion and order denying over 30 separate motions to dismiss filed by 15 generic manufacturers named as defendants in the Generic Pharmaceuticals Pricing Antitrust multidistrict litigation.  The Generic Pricing MDL alleges a conspiracy among numerous generic manufacturers to...

Read full post

Bitcoin Price Plummets Amid Reports of Regulatory Scrutiny and Market Manipulation

October 10th, 2018

Bitcoin’s price has decreased 60% since reaching its record high last year.  This can be attributed to at least two factors: regulatory scrutiny and market manipulation. Regulatory Scrutiny: This past August, the Securities and Exchange Commission (the “SEC”) rejected nine applications for cryptocurrency exchange traded funds.  These funds, which are baskets of cryptocurrencies bundled...

Read full post

Page 2 of 59
Logo Twitter Facebook LinkedIn Google+